Data · dataset · 2026
Fig 6 - <p> </p>
Listed in ZivaHub
Description
<p><i>S</i><i>. aureus</i> Sph activates STING to promote autophagy-lysosome-dependent GPX4 degradation and ferroptosis. <b>(A)</b> Expression of GPX4 protein in HC11 cells treated with 32 μg/mL recombinant Sph and C-176 (5 μM) for 6 h. <b>(B)</b> Expression of of LC3B-I and LC3B-II levels in HC11 cells treated with recombinant Sph (32 μg/mL) for 6 h. <b>(C)</b> GPX4 expression in HC11 cells treated with recombinant Sph (32 μg/mL) alone or in combination with NH<sub>4</sub>Cl (10 mM) or chloroquine (20 μM) for 6 h. <b>(D)</b> Expression of GPX4 protein in HC11 cells treated with 32 μg/mL recombinant Sph alone or in combination with 3-MA (5 mM) or bafilomycin A1 (100 nM) for 6 h. <b>(E-G)</b> Representative confocal images and corresponding colocalization analyses of STING with GPX4 <b>(E)</b>, LC3B with GPX4 <b>(F)</b>, and LAMP2B with GPX4 <b>(G)</b> in HC11 cells treated with recombinant Sph (32 μg/mL), cGAMP (2 μg/mL), or C-176 (5 μM), as indicated, for 6 h.
Scale bars, 10 μm. <b>(H, I)</b> Reciprocal co-immunoprecipitation analysis of Flag-GPX4 and Myc-STING in co-transfected NIH/3T3 cells using anti-Flag (H) or anti-Myc <b>(I)</b> antibodies. <b>(J)</b> Ratiometric imaging of Golgi luminal pH in NIH/3T3 cells expressing MGAT2-RpHLuorin2 following treatment with cGAMP (2 μg/mL) or bafilomycin A1 (100 nM). The 405/488 nm fluorescence ratio was used as an indicator of Golgi pH (MGAT2-RpHLuorin2).
Read the rest (1 more)
Data are presented as mean ± SD (n = 3). *<i>P</i> < 0.05; **<i>P</i> < 0.01; ns, not significant.</p>
Links
Where it is published
- DOI doi.org/10.1371/journal.ppat.1014644.g006 ↗
DOI / persistent id · from zivahub uct ac za
Catalogue records · 1
- OAI-PMH record api.figshare.com/v2/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Af… ↗
metadata API · from zivahub uct ac za
Topics
Provenance · 1 source records, 17 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| ZivaHub | oai:figshare.com:article/34026603 | 9 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].anzsrc:field:310706 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Virology'] |
| concepts[field].anzsrc:field:320211 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Infectious Diseases'] |
| concepts[field].anzsrc:field:440710 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Science Policy'] |
| concepts[field].anzsrc:group:3101 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Cell Biology'] |
| concepts[field].anzsrc:group:3105 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Genetics'] |
| concepts[field].anzsrc:group:3107 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Microbiology'] |
| concepts[field].anzsrc:group:3204 | mapping · zivahub uct ac za | vocabulary-mapper@1.0.0 | keywords['Immunology'] |
| concepts[field].local:field:earth-environmental | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].local:field:life-sciences | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].local:field:medicine-health | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[modality].local:modality:image | enrichment · zivahub uct ac za | keyword-concept-rules@1.0.0 | title+description (65%) |
| concepts[modality].local:modality:imaging | enrichment · zivahub uct ac za | keyword-concept-rules@1.0.0 | title+description (75%) |
| description | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/description |
| license | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/rights |
| publication_date | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| title | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/title |